Matriks Biotechnology is a medical biotechnology company founded by Prof. Haluk Ataoglu MD, PhD  in 2002.  Company conducts research on life sciences and medical biotechnology, develops and offers its products at a global scale for helping people to lead a better life. The company has celebrated its 20th anniversary in 2022.

Matriks Biotek® globally is the first company to produce and to commercialize ELISA kits to monitor biotherapy under the brand name of SHIKARI® since 2008 and with its products creating a world market for therapeutic drug monitoring for large molecules.

The company has 100 different SHIKARI® ELISA kits for 36 biological drugs and 16 different CoronaHunter® ELISA kits for the determination of Covid-19 antibodies. Matriks Biotek supplies a total of 116 ELISA kits which are the widest range of products with top quality and unique in these respective fields. There are over 10 new kits in our pipeline completed and will be launched very soon. There are over 170 publications done by using SHIKARI® and CoronaHunter®   brands’ ELISA kits please refer to https://matriksbiotek.com/publications

The company has a very quick technical support response and complaint rate is below only 0.5%.

Production is conducted with expert scientists in accordance with ISO 13485:2016 quality management system and the company has CE-IVD mark for all their products for Europe.


*Matriks Biotek®, SHIKARI®, KLONART®, CoronaHunter® and CandidaHunter® are registered Trademarks of Matriks Biotechnology Co. Ltd.

To ask for a quotation and to have more information send an e-mail to us:
info@matriksbiotek.com
www.matriksbiotek.com
https://www.linkedin.com/company/matriks-biotechnology-co-/

Matriks Biotechnology Co.

Org chart

Teams

Offices